MIC2 analysis in pediatric lymphomas and leukemias
Authors:
- Paul S. DickmanPDPaul S. Dickman
- Michael P. LinkMLMichael P. Link
- Elizabeth J. PerlmanEPElizabeth J. Perlman
Open Access
- 1 April 1994
- journal article
- Published by Elsevier in Human Pathology
- Vol. 25 (4) , 396-399
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of Cell Surface Antigen HBA71 (p30/32MIC2), Neuron-Specific Enolase, and Vimentin in the Immunohistochemical Analysis of Ewingʼs Sarcoma of BoneAmerican Journal of Surgical Pathology, 1992
- Mediastinal Lymphoblastic Lymphoma With an Immature B-Cell ImmunophenotypeAmerican Journal of Surgical Pathology, 1992
- Non-T-Cell Lymphoblastic Lymphoma With Extensive Osteolytic Lesions and HypercalcemiaSouthern Medical Journal, 1991
- MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberrationCancer, 1991
- A Case of Lymphoblastic Lymphoma with Pre-B Cell PhenotypeActa Haematologica, 1991
- The E2 antigen, a 32 kd glycoprotein involved in T‐cell adhesion processes, is the MIC2 gene product.The EMBO Journal, 1989
- Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behaviorCancer, 1987
- Expression of leukocyte common antigen in lymphoblastic lymphoma and small noncleaved undifferentiated non‐Burkitt's lymphoma: An immunohistochemical studyThe Journal of Pathology, 1987
- A Pseudoautosomal Gene in ManScience, 1986
- Cutaneous lymphoblastic lymphoma with pre-B markersBlood, 1983